Birth control vaccine targeting leukemia inhibitory factor

Molecular Reproduction and Development

Volumn 79, Issue 2, 2012, Pages 97-106

  Lemons, Angela R ^a   Naz, Rajesh K ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH CONTROL VACCINE; CARRIER PROTEIN; CONTRACEPTIVE AGENT; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; PEPTIDE VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BIRTH CONTROL; CELL CULTURE; CONTRACEPTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONJUGATION; DRUG RECEPTOR BINDING; DRUG TARGETING; FEMALE; FERTILITY; IMMUNE RESPONSE; IMMUNOGENICITY; LIGAND BINDING; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; CELLS, CULTURED; CONTRACEPTION; CONTRACEPTION, IMMUNOLOGIC; EMBRYO IMPLANTATION; FEMALE; FERTILITY; LEUKEMIA INHIBITORY FACTOR; MALE; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PREGNANCY; RABBITS; VACCINES, CONTRACEPTIVE;

MAMMALIA; MUS;

EID: 84855963096     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.22002     Document Type: Article

References (43)

1. Chaouat G, Menu E, Delage G, Moreau JF, Khrishnan L, Hui L, Meliani AA, Martal J, Raghupathy R, Lelaidier C. 1995. Immuno-endocrine interactions in early pregnancy. Hum Reprod 10: 55-59.
2. Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK. 1994. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 2: 421-426.
3. Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA, Stewart CL. 1996. Leukemia, inhibitory factor (LIF) and LIF receptor expression in human endometrium suggest a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci USA 93: 3115-3120.
4. Delage G, Moreau JF, Taupin JL, Freitas S, Hambartsoumian E, Olivennes F, Franchin R, Letur-Konirsh H, Frydman R, Chaouat G. 1995. In-vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum Reprod 10: 2483-2488.
5. Gearing DP, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D. 1987. Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor (LIF). EMBO J 6: 3995-4002.
6. Gearing DP, King JA, Gough NM. 1988. Complete Sequence of murine myeloid leukemia inhibitory factor (LIF). Nucleic Acids Res 16: 9857-9857.
7. Henshaw SK. 1998. Unintended pregnancy in the United States. Fam Plann Perspect 30: 24-29.
8. Hill EJ, Vernallis AB. 2008. Polarized secretion of leukemia inhibitory factor. BMC Cell Biol 9: 53
9. Hu W, Feng Z, Teresky AK, Levin AJ. 2007. P53 regulates maternal reproduction through LIF. Nature 450: 721-724.
10. Hudson KR, Vernallis AB, Heath JK. 1996. Characterization of the receptor binding sites of human leukemia inhibitory factor and creation of antagonists. J Biol Chem 271: 11971-11978.
11. Huyton T, Zhang JG, Luo CS, Lou MZ, Hilton DJ, Nicola NA, Garrett TP. 2007. An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor. (LIF) in complex with the LIF receptor. Proc Natl Acad Sci USA 104: 12737-12742.
12. Karow J, Hudson KR, Hall MA, Vernallis AB, Taylor JA, Gossler A, Heath JK. 1996. Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor. Biochem J 318: 489-495.
13. Kimber SJ. 2005. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction 130: 131-145.
14. Lemons AR, Naz RK. 2011. Contraceptive vaccines targeting factors involved in establishment of pregnancy. Am J Reprod Immunol 66: 13-25.
15. Liu MA. 2003. DNA vaccines: A review. J Intern Med 253: 402-410.
16. McKenzie SJ, Halsey JF. 1984. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J Immunol 133: 1818-1824.
17. Naz RK. 2008. Immunocontraceptive effect of Izumo and enhancement by combination vaccination. Mol Reprod Dev 75: 336-344.
18. Naz RK. 2011a. Contraceptive vaccines: Success, status and future perspective. Am J Reprod Immunol 66: 2-4.
19. Naz RK. 2011b. Antisperm contraceptive vaccines: Where we are and where we are going? Am J Reprod Immunol 66: 5-12.
20. Naz RK. 2012. Female genital tract immunity: Distinct immunological challenge and vaccine development. J Reprod Immunol (in press).
21. Naz RK, Ahmad K, Menge AC. 1993. Antiidiotypic antibodies to sperm in sera of fertile women that neutralize antisperm antibodies. J Clin Invest 92: 2331-2338.
22. Naz RK, Butler A, Witt BR, Barad D, Menge AC. 1995. Levels of interferon-gamma and tumor necrosis factor-α in sera and cervical mucus of fertile and infertile women: Implication in infertility. J Reprod Immunol 29: 105-117.
23. Naz RK, Chauhan SC. 2002. Human sperm-specific peptide vaccine that causes long-term reversible contraception. Biol Reprod 67: 674-680.
24. Naz RK, Gupta SK, Gupta JC, Vyas HK, Talwar GP. 2005. Recent advances in contraceptive vaccine development: A mini-review. Hum Reprod 20: 3271-3283.
25. Novotny Z, Krizan J, Sima R, Sima P, Uher P, Zech N, Hutelova R, Baborova P, Ulcova-Gallova Z, Subrt I, Ulmanova E, Houdek Z, Rokyta Z, Babuska V, Kralickova M. 2009. Leukaemia inhibitory factor (LIF) gene mutations in women diagnosed with unexplained infertility and endometriosis have a negative impact on the IVF outcome. A pilot study. Folia Biol (Praha) 55: 92-97.
26. Patil SD, Rhodes DG, Burgess DJ. 2005. DNA-based therapeutics and DNA delivery systems: A comprehenseive review. AAPS J 7: E61-E77.
27. Purswani S, Talwar GP, Vohra R, Pal R, Panda AK, Lohiya NK, Gupta JC. 2011. Mycobacterium indicus pranii is a potent immunomodulator for a recombinant vaccine against human chorionic gonadotropin. J Reprod Immunol 91: 24-30.
28. Robb L, Dimitriadis E, Li R, Salamonsen LA. 2002. Leukemia inhibitory factor and interleukin 11: Cytokines with key roles in implantation. J Reprod Immunol 57: 129-141.
29. Robinson HL. 1999. DNA vaccines: Basic mechanism and immune responses. Int J Mol Med 4: 549-555.
30. Sengupta J, Laltkumar PG, Najway AR, Ghosh D. 2006. Monoclonal anti-leukemia inhibitory factor antibody inhibits blastocyst implantation in the rhesus monkey. Contraception 74: 419-425.
31. Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock-Jones S, Smith SK. 1995. Stage specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. Biol Reprod 53: 974-981.
32. Singh M, Das SK, Suri S, Singh O, Talwar GP. 1998. Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine. Am J Reprod Immunol 39: 395-398.
33. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. 1992. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359: 76-79.
34. Talwar GP, Singh O, Pal R, Chatterjee N, Sahai P, Dhall K, Kaur J, Das SK, Suri S, Buckshee K, Saraya L, Saxena BN. 1994. A vaccine that prevents pregnancy in women. Proc Natl Acad Sci USA 91: 8532-8536.
35. Talwar GP, Gupta JC, Shankar NV. 2011. Immunological approaches against human chorionic gonadotropin for control of fertility and therapy of advanced-stage cancers expressing hCG/subunits. Am J Reprod Immunol 66: 26-39.
36. Terakawa J, Wakitani S, Sugiyama M, Inoue N, Ohmori Y, Kiso Y, Hosaka YZ, Hondo E. 2011. Embryo implantation is blocked by intraperitoneal injection with anti-LIF antibody in mice. J Reprod Dev 2011 Aug 12 [Epub ahead of print].
37. Trussel J. 2004. Contraceptive failure in the United States. Contraception 70: 89-96.
38. Underhill-Day N, McGovern LA, Karpovich N, Mardon HJ, Barton VA, Heath JK. 2003. Functional characterization of W147A: A high-affinity interleukin-11 antagonist. Endocrinology 144: 3406-3414.
39. Vogiagis D, Marsh MM, Fry RC, Salamonsen LA. 1996. Leukaemia inhibitory factor in human endometrium throughout the menstrual cycle. J Endrocinol 1: 95-102.
40. Whalen RG. 1996. DNA vaccines for emerging infectious diseases: What if? Emerg Infect Dis 2: 168-175.
41. White CA, Zhang JG, Salamonsen LA, Baca M, Fairlie WD, Metcalf D, Nicola NA, Robb L, Dimitriadis E. 2007. Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: A nonhormonal contraceptive strategy. Proc Natl Acad Sci USA 104: 19357-19362.
42. WHO/63. 2006. News Release, November 1, .
43. World POPClock Projection. 2011. US Census Bureau [online], (September 13, 2011. date accessed).